findmyKOL

Wendy Marder, MD

Basic profile

University of Michigan

ORCIDNPI
RegionAnn Arbor, MI · MidwestSpecialtyRheumatologyFocusRheumatology/Immunology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Wendy Marder is a Rheumatology/Immunology physician affiliated with University of Michigan. OpenAlex indexes 72 publications with 3,472 citations (h-index 26); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
72publications

Distinct works indexed by OpenAlex, matched via ORCID.

3,472citations

Total citations across indexed works.

26h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1500 East Medical Center Dr
3rd Floor Taubman Ctr Recp A
Ann Arbor, MI 481095370

Telephone

734-647-5900

Registry record last updated 21 Mar 2012.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    42.3%
    TNF inhibitor10.9%
    Simponi29%Enbrel Sureclick27%Humira(Cf) Pen24%Humira Pen11%Humira(Cf)10%
    Part D<11 patients
    Folate Analog Metabolic Inhibitor9.8%
    Methotrexate100%
    Part D34 patients

    + 6 more classes in this area

  • Metabolism & gastrointestinal

    20.5%
    Corticosteroid15.2%
    Prednisone100%
    Part D57 patients
    Antidiarrheal microorganisms2.3%
    Folic Acid100%
    Part D<11 patients

    + 2 more classes in this area

  • Antiparasitic

    16.4%
    Antimalarial16.4%
    Hydroxychloroquine Sulfate100%
    Part D63 patients
Where care is delivered (Part B)39.9% facility · 60.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”